Triglav Skladi, D.O.O. Exact Sciences Corp Transaction History
Triglav Skladi, D.O.O.
- $1.2 Trillion
- Q1 2025
A detailed history of Triglav Skladi, D.O.O. transactions in Exact Sciences Corp stock. As of the latest transaction made, Triglav Skladi, D.O.O. holds 18,250 shares of EXAS stock, worth $1.02 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
18,250
Previous 18,250
-0.0%
Holding current value
$1.02 Million
Previous $1.03 Billion
22.96%
% of portfolio
0.07%
Previous 0.08%
Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
644Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$1 Billion0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$990 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$702 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$677 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$371 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.93B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...